Changes in the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related hospitalizations.
Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal
Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of